CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Portable Stroke Diagnosis Devices for Adults with Stroke Symptoms: A Review of Diagnostic Accuracy and Cost-Effectiveness

Last updated: July 2, 2019
Project Number: RC1151-000
Product Line: Rapid Response
Research Type: Devices and Systems
Report Type: Summary with Critical Appraisal
Result type: Report


  1. What is the diagnostic accuracy of portable stroke diagnostic devices for adults with stroke symptoms?
  2. What is the cost-effectiveness of portable stroke diagnostic devices for adults with stroke symptoms?

Key Message

One relevant non-randomized study was identified regarding diagnostic accuracy of bioimpedance spectroscopy visors for adults with stroke symptoms. This evidence of limited quality suggested that the device accurately differentiated patients requiring severe stroke triage from those who were healthy or who experienced a minor stroke, with a sensitivity of 93% and specificity of 87%.No evidence regarding the diagnostic accuracy of the combination device (i.e., combination of transcranial Doppler ultrasound, robotic headset blood flow monitor, and machine learning) or of the microwave tomography system for adults with stroke symptoms was identified. Additionally, no evidence regarding the cost-effectiveness of the portable stroke diagnostic devices of interest was identified.The limitations of the included study (e.g., its open-label nature, unclear recruitment methods, industry-funded status, and potentially limited generalizability) and of this report should be considered when interpreting the results. Further research on the diagnostic test accuracy and cost-effectiveness of portable stroke diagnostic devices in adults with stroke symptoms could reduce this uncertainty.